
AGENDA
Agenda
Friday, July 20, 2018
8:00 - 8:50 AM
Registration Check-in & Networking Breakfast
8:50 - 9:00 AM
Welcome & Opening Remarks
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus
9:00 - 9:20 AM
Foundation Fighting Blindness Emerging Science Showcase
Introduced By:
Jason Menzo, COO - Foundation Fighting Blindness
Discovery of an Intravitreal AAV Vector, 4D-R100, for Use in Retina Gene Therapeutics
David Kirn, MD, CEO & Co-Founder - 4D Molecular Therapeutics
Next generation approaches to optogenetics
John G. Flannery, PhD, Professor - Photoswitch Therapeutics
RNA treatments targeting rare diseases
Daniel de Boer, CEO - ProQR Therapeutics
Retinal regeneration and photoreceptor reprogramming
Tom Reh, PhD, Professor, Department of Biological Structure - University of Washington
9:20 - 10:08 AM
Private Company Showcase
Introduced By:
Patrick Healy, Co-Founder, Executive Chairman - Trial Runners
ONL Therapeutics | John Freshley, President & CEO
RFE Pharma | Alan Franklin, MD, PhD, Chief Medical Officer
Ocugenix | Sean McDonald, President & CEO
iRenix Medical | Stephen Smith, Founder & CEO
Eyedaptic | Jay Cormier, CEO
ZeaVision Holdings | Pinakin Davey, Professor and Director of Research - Western University, College of Optometry
Graybug Vision | Jeffrey Cleland, President & CEO
Allegro Ophthalmics | Vicken Karageozian, MD, President & Chief Medical Officer
10:08 - 10:46 AM
AM Networking & Refreshment Break
10:46 - 11:26 AM
Public Company Showcase
Introduced By:
Susan Benton, Head of Global Franchise Strategy and New Products, Ophthalmology - Shire
Aerie Pharmaceuticals | Theresa Heah, MD, VP, Clinical Research, Medical and Professional Affairs
EyePoint Pharmaceuticals | Leonard Blum, EVP & General Manager, U.S.
Clearside Biomedical | Brion Raymond, Chief Commercial Officer
GenSight Biologics | Barrett Katz, MD, Chief Medical Officer
Spark Therapeutics | Thomas Ciulla, MD, Medical Strategy Lead, Ophthalmology
11:26 - 11:44 AM
Advances in Retinal Imaging 2018
Introduced By:
Craig Simak, Co-Founder - OIS/CEO – Healthegy
Carl Zeiss Meditec | Angelo Rago, Global Head, Ophthalmic Diagnostics - Carl Zeiss Meditec
Heidelberg Engineering | Paul Bernstein MD, PhD, Professor of Ophthalmology and Visual Sciences - Moran Eye Center, University of Utah
Leica Microsystems | Houston Powell Sharpe III, Lead OCT Application Specialist - Leica Microsystems
11:44 - 11:50 AM
Public Market Trends in Ophthalmology
Presented By:
Andrew Gitkin, Head of West Coast Biotechnology Investment Banking - Piper Jaffray
11:50 - 12:25 PM
Financing Environments 2018
Participants:
Angela Macfarlane, Managing Member - ForSight Labs
Firas M. Rahhal, MD, Partner - ExSight Ventures
Ron Weiss, MD, Managing Member - InFocus Capital Partners
Cameron Wheeler, Principal - Deerfield Management
Moderated By:
William J. Link, PhD, Managing Director - Versant Ventures
12:25 - 1:15 PM
Networking Lunch
1:15 - 1:50 PM
Retinal Drug Delivery
Participants:
Mark Balles, MD, Founder - Retina Center of Maine
Eugene de Juan, MD, Founder & Managing Partner - ForSight Labs
Greg Grunberg, MD, Managing Director - Longitude Capital
Mark Wieland, MD - Northern California Retina Vitreous Associates
Daniel White, President & CEO - Clearside Biomedical
Moderated By:
Gilbert H. Kliman, MD, Managing Director - InterWest Partners
1:50 - 2:25 PM
Combination Therapies in AMD and DME
Participants:
David Boyer, MD, Retina-Vitreous Associates Medical Group
Jason Ehrlich, MD, PhD, Global Head, Clinical Ophthalmology Product Development - Genentech
Dante Pieramici, MD, Partner - California Retina Consultants
Charles Wykoff, MD - Retina Consultants of Houston
Moderated By:
Peter Kaiser, MD, Professor of Ophthalmology - Cole Eye Institute
2:25 - 2:55 PM
PM Networking & Refreshment Break
2:55 - 3:30 PM
Retinal Gene Therapy 2018
Participants:
Thomas Ciulla, MD, Medical Strategy Lead, Ophthalmology - Spark Therapeutics
Karl Csaky, MD, T. Boone Pickens Director - Clinical Center of Innovation for AMD/Managing Director & Chief Medical Officer - Retina Foundation of the Southwest
Barrett Katz, MD, Chief Medical Officer - GenSight Biologics
David Kirn, MD, CEO & Co-Founder - 4D Molecular Therapeutics
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus
3:30 - 4:05 PM
Masters of Retina
Participants:
Anthony Adamis, MD, SVP, Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science - Genentech
Kfir Azoulay, VP & Head, Corporate Strategy - Heidelberg Engineering
David Nicholson, PhD, Chief R&D Officer - Allergan
Angelo Rago, Global Head, Ophthalmic Diagnostics - Carl Zeiss Meditec
Calvin Roberts, MD, SVP, Chief Medical Officer - Bausch + Lomb
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec
4:05 - 4:10 PM
Closing Remarks
William J. Link, PhD, Managing Director - Versant Ventures